You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1806130 |
---|---|
Category | Antibodies |
Description | Anti-TNFRSF4 / OX40 / CD134 Reference Antibody is expressed from CHO. It has a predicted MW of 145.5 kDa. |
Clonality | Monoclonal |
Tested applications | ELISA, FA, FACS, Kinetics |
Reactivity | Human |
Isotype | IgG |
Purity | > 95% |
Conjugation | Unconjugated |
MW | 145.5 kDa |
Target | TNFRSF4 / OX40 / CD134 |
Endotoxins | < 1 EU/mg |
Storage | -80°C |
Buffer/Preservatives | 100 mM Pro-Ac 20 mM Arg pH 5.0 |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |
Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (tavolixizumab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.
The purity of Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (tavolixizumab)is more than 97.98% ;determined by SEC-HPLC.
Immobilized human CD134 His at 2 μg/mL can bind Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (tavolixizumab);EC50=0.03236μg/mL.
ELISA, FA, FACS, Kinetics | |
Human | |
Monoclonal | |
Unconjugated |
ELISA, FA, FACS, Kinetics | |
Human | |
Monoclonal | |
Unconjugated |
ELISA, FA, FACS, Kinetics | |
Human | |
Monoclonal | |
Unconjugated |
ELISA, FA, FACS, Kinetics | |
Human | |
Monoclonal | |
Unconjugated |
ELISA, FA, FACS, Kinetics | |
Human | |
Monoclonal | |
Unconjugated |
Filter by Rating